Edward Goldstein
Biographic Data
| ID | 7092147 |
|---|---|
| NAME | Edward Goldstein |
| GIVEN NAMES | Edward |
| FAMILY NAME | Goldstein |
| SIGNATURE | GOLDSTEIN E |
| AFFILIATIONS | Center for Disease Dynamics, Economics & Policy |
| ORCID | 0000-0002-6795-0559 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
Projecting the transmission dynamics of Sars-CoV-2 through the postpandemic period
What happens next? Four months into the severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) outbreak, we still do not know enough about postrecovery immune protection and environmental and seasonal influences on transmission to predict transmission dynamics accurately. However, we do know that humans are seasonally afflicted by other, less severe coronaviruses. Kissler et al. used existing data to build a deterministic model of multiyear…
Levels of outpatient prescribing for four major antibiotic classes and rates of septicemia hospitalization in adults in different US states - a statistical analysis
Our results suggest positive associations between the rates of prescribing for penicillins and the rates of hospitalization with septicemia in US adults aged 50-84y. Further studies are needed to better understand the potential effect of antibiotic replacement in the treatment of various syndromes, including the potential impact of the recent US FDA guidelines on restriction of fluoroquinolone use, as well as the potential effect of changes in th…
No prominent works on this page.
Levels of outpatient prescribing for four major antibiotic classes and rates of septicemia hospitalization in adults in different US states - a statistical analysis
Our results suggest positive associations between the rates of prescribing for penicillins and the rates of hospitalization with septicemia in US adults aged 50-84y. Further studies are needed to better understand the potential effect of antibiotic replacement in the treatment of various syndromes, including the potential impact of the recent US FDA guidelines on restriction of fluoroquinolone use, as well as the potential effect of changes in th…
Projecting the transmission dynamics of Sars-CoV-2 through the postpandemic period
What happens next? Four months into the severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) outbreak, we still do not know enough about postrecovery immune protection and environmental and seasonal influences on transmission to predict transmission dynamics accurately. However, we do know that humans are seasonally afflicted by other, less severe coronaviruses. Kissler et al. used existing data to build a deterministic model of multiyear…
Intensive care medicine (2 works) · Medicine (2 works) · Antibiotic Use and Resistance (1 work) · Antibiotics (1 work) · Bacterial Identification and Susceptibility Testing (1 work) · Biostatistics (1 work) · Cephalosporin (1 work) · Computer Science (1 work) · Coronavirus (1 work) · Coronavirus disease 2019 (COVID-19) (1 work)